Terrasil Tinea Treatment MAX

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Terrasil Tinea Treatment MAX
Generic name: CLOTRIMAZOLE
Manufacturer: Aidance Scientific, Inc., DBA Aidance Skincare & Topical Solutions
Product type: HUMAN OTC DRUG
SPL set ID: d0b14dcb-89a7-42f6-b6ae-8f19c4e6aaaa
SPL ID: 39b218a2-6f29-34c9-e063-6294a90aa1d4
Version: 8
Effective date: 2025-07-11
Source export date: 2026-09-28
Source partition: 5
Source file: https://download.open.fda.gov/drug/label/drug-label-0005-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/9839785a692b692224cd5f90f9e3a9514c9923a6f521ab83eed3bedc7c0e1d05/drug-label-0005-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:33:57

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 23 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M005	openfda.application_number
brand name		Terrasil Tinea Treatment MAX	openfda.brand_name
generic name		CLOTRIMAZOLE	openfda.generic_name
manufacturer name		Aidance Scientific, Inc., DBA Aidance Skincare & Topical Solutions	openfda.manufacturer_name
ndc	package	24909-104-44	openfda.package_ndc
ndc	package	24909-104-20	openfda.package_ndc
ndc	package	24909-104-28	openfda.package_ndc
ndc	package	24909-104-50	openfda.package_ndc
ndc	package	24909-104-15	openfda.package_ndc
ndc	package	24909-104-14	openfda.package_ndc
ndc	package	24909-104-21	openfda.package_ndc
ndc	product	24909-104	openfda.product_ndc
ndc11	package	24909010414	derived:openfda.package_ndc
ndc11	package	24909010421	derived:openfda.package_ndc
ndc11	package	24909010428	derived:openfda.package_ndc
ndc11	package	24909010420	derived:openfda.package_ndc
ndc11	package	24909010444	derived:openfda.package_ndc
ndc11	package	24909010450	derived:openfda.package_ndc
ndc11	package	24909010415	derived:openfda.package_ndc
rxcui		418475	openfda.rxcui
spl id		39b218a2-6f29-34c9-e063-6294a90aa1d4	id
spl set id		d0b14dcb-89a7-42f6-b6ae-8f19c4e6aaaa	set_id
unii		G07GZ97H65	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only . Do not use on children under two years of age unless directed by a physician. Avoid contact with the eyes. If irritation occurs or if there is no improvement within 4 weeks, discontinue use and consult a physician.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.